Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Withdrawn 1Terminated 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 3Gastrointestinal 1CNS 1

Conditions

Head and Neck Neoplasms 14Squamous Cell Carcinoma of Head and Neck 7Thyroid Neoplasms 6Tongue Neoplasms 4Salivary Gland Neoplasms 3Carcinoma, Squamous Cell 3Thyroid Carcinoma, Anaplastic 2Thyroid Cancer, Papillary 2Carcinoma, Medullary 2Adenocarcinoma, Follicular 2Xerostomia 1Thyroid cancer, Hurthle cell 1Thyroid Diseases 1Neoplasms, Squamous Cell 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Lymphoma 1Locally Advanced Thyroid Gland Carcinoma 1Hereditary Sensory and Autonomic Neuropathies 1Esthesioneuroblastoma, Olfactory 1Differentiated Thyroid Cancer 1Colonic Neoplasms 1

Interventions

Cisplatin 19Docetaxel 17Cetuximab 12Carboplatin 12Radiotherapy 11Magnetic Resonance Spectroscopy 10Biopsy 10pembrolizumab 9Paclitaxel 9Radiotherapy, Intensity-Modulated 8Immunohistochemistry 8Erlotinib Hydrochloride 8Trastuzumab 7Gemcitabine 7Chemotherapy, Adjuvant 7Specimen Handling 6Radiotherapy, Conformal 5Radiosurgery 5Gene Expression Profiling 5Fluorodeoxyglucose F18 5Capecitabine 5Vorinostat 4Taxes 4Sorafenib 4Polymerase Chain Reaction 4Nivolumab 4Bevacizumab 4trastuzumab deruxtecan 3sargramostim 3bicalutamide 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Salivary Gland Neoplasms × Everolimus × Head & Neck × Clear all
NCT01332279 2023-04-04

Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation Therapy

Fox Chase Cancer Center

Phase 1 Withdrawn
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms, Tongue Neoplasms

NCT01637194 2012-07-11

Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer

Fox Chase Cancer Center

Phase 1 Completed
12 enrolled
CNSGastrointestinalHead & Neck

Squamous Cell Carcinoma of Head and Neck, Colonic Neoplasms, Salivary Gland Neoplasms, Tongue Neoplasms, Esthesioneuroblastoma, Olfactory

NCT01313390 2011-12-12

DORA

University College, London

Phase 1/2 Terminated
4 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡